VanTrust to Build Sephora’s New Midwest Distribution Center
The facility will come online next year.
VanTrust Real Estate will develop a 746,672-square-foot build-to-suit facility for Sephora in Avon, Ind. The 61-acre property will serve as the beauty retailer’s Midwest distribution center and is scheduled to come online next summer.
This marks the second collaboration between the two companies. In 2019, VanTrust completed Tropical Distribution Center 2, a 715,000-square-foot facility in North Las Vegas that is fully occupied by the cosmetics supplier.
Development partners for the upcoming facility include general contractor Pepper Construction, architecture firm MacGregor Architects and civil engineer American Structurepoint. The building is designed to meet LEED Silver certification. CBRE Executive Vice Presidents Toby Mink and Andrew Morris arranged the deal on behalf of Sephora.
READ ALSO: I.CON East Special Report: Industrial Opportunity Snapshot
VanTrust will build the distribution center within its Avon Landings Commerce Park, a two-phase industrial project measuring 119 acres. The developer broke ground on the first three speculative buildings two years ago, of which one has already been completed. Together with the upcoming Sephora distribution center, the campus will encompass nearly 1.5 million square feet.
The industrial park is on Ronald Reagan Parkway, allowing access to interstates 465 and 74. The Indianapolis International Airport is within 8 miles, while downtown Indianapolis is some 12 miles east.
Indianapolis’ steady industrial sector
Despite increased construction costs, Indianapolis had nearly 4.8 million square feet of space under construction as of May, representing 1.3 percent of existing stock, according to the latest CommercialEdge industrial report. Additionally, the market’s vacancy rate was 4.7 percent, 90 basis points lower than the national average.
In May, Eli Lilly and Co. announced a $5.3 billion investment at its Lebanon, Ind., manufacturing site. This new funding is aimed at enhancing production capabilities for ingredients used in Zepbound and Mounjaro, which are injectable antidiabetic and weight loss drugs. Production at the 600-acre campus is expected to start at the end of 2026.
You must be logged in to post a comment.